The following articles (labelled with PubMed ID or TBD) are for your reviewPMID | Article Title | Published | Deposition |
---|
11259322 |
Carrier-mediated hepatobiliary transport of a novel antifolate, N-[4-[(2,4-dianninopteridine-6-yl)methyl]-3,4-dihydro-2H-1,4-benzothiazin-7-yl]carbonyl-L-homoglutamic acid, in rats. |
XX-APR-2001 |
30-AUG-2020 |
10997946 |
Selective inhibition of human cytochrome P450 3A4 by N-[2(R)-hydroxy-1(S)-indanyl]-5-[2(S)-(1, 1-dimethylethylaminocarbonyl)-4-[(furo[2, 3-b]pyridin-5-yl)methyl]piperazin-1-yl]-4(S)-hydroxy-2(R)-phenylmethy lpentanamide and P-glycoprotein by valspodar in gene transfectant systems. |
XX-OCT-2000 |
30-AUG-2020 |
15618649 |
The potential for an interaction between MRP2 (ABCC2) and various therapeutic agents: probenecid as a candidate inhibitor of the biliary excretion of irinotecan metabolites. |
XX-XXX-2002 |
30-AUG-2020 |
9262353 |
Kinetic analysis of the primary active transport of conjugated metabolites across the bile canalicular membrane: comparative study of S-(2,4-dinitrophenyl)-glutathione and 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)benzothiazole glucuronide. |
XX-AUG-1997 |
30-AUG-2020 |
9103511 |
Multispecific organic anion transporter is responsible for the biliary excretion of the camptothecin derivative irinotecan and its metabolites in rats. |
XX-APR-1997 |
30-AUG-2020 |
11465411 |
Physicochemical parameters responsible for the affinity of methotrexate analogs for rat canalicular multispecific organic anion transporter (cMOAT/MRP2). |
XX-MAY-2001 |
30-AUG-2020 |
11961115 |
Expression and functional characterization of rat organic anion transporter 3 (rOat3) in the choroid plexus. |
XX-MAY-2002 |
30-AUG-2020 |
14675047 |
Characterization of uremic toxin transport by organic anion transporters in the kidney. |
XX-JAN-2004 |
29-AUG-2020 |
9464355 |
Novel potent nonpeptide aminopeptidase N inhibitors with a cyclic imide skeleton. |
29-JAN-1998 |
22-AUG-2020 |
9873660 |
Preparation of biotinylated allosamidins with strong chitinase inhibitory activities. |
03-NOV-1998 |
10-OCT-2018 |
9873473 |
Asymmetric synthesis of antimitotic combretadioxolane with potent antitumor activity against multi-drug resistant cells. |
04-AUG-1998 |
09-OCT-2018 |
11861777 |
Functional involvement of rat organic anion transporter 3 (rOat3; Slc22a8) in the renal uptake of organic anions. |
25-FEB-2002 |
22-MAY-2013 |
16610783 |
Practical synthesis and evaluation of the biological activities of 1alpha,25-dihydroxyvitamin D3 antagonists, 1alpha,25-dihydroxyvitamin D3-26,23-lactams. Designed on the basis of the helix 12-folding inhibition hypothesis. |
13-APR-2006 |
20-MAY-2013 |
9756510 |
Reduced folate derivatives are endogenous substrates for cMOAT in rats. |
23-NOV-1998 |
08-FEB-2013 |
9918561 |
Primary active transport of peptidic endothelin antagonists by rat hepatic canalicular membrane. |
22-FEB-1999 |
08-FEB-2013 |
9495864 |
Carrier-mediated mechanism for the biliary excretion of the quinolone antibiotic grepafloxacin and its glucuronide in rats. |
09-APR-1998 |
08-FEB-2013 |
18162399 |
SAR-oriented discovery of peroxisome proliferator-activated receptor pan agonist with a 4-adamantylphenyl group as a hydrophobic tail. |
05-FEB-2008 |
15-DEC-2012 |
16617018 |
Diphenylmethane skeleton as a multi-template for nuclear receptor ligands: preparation of FXR and PPAR ligands. |
08-MAY-2006 |
07-DEC-2012 |
10843222 |
Novel alpha-glucosidase inhibitors with a tetrachlorophthalimide skeleton. |
02-OCT-2000 |
01-OCT-2012 |
10098663 |
Nonpeptide small-molecular inhibitors of dipeptidyl peptidase IV: N-phenylphthalimide analogs. |
24-MAY-1999 |
30-SEP-2012 |
15901796 |
Bile salt export pump (BSEP/ABCB11) can transport a nonbile acid substrate, pravastatin. |
XX-XXX-2005 |
08-JUN-2012 |
17584609 |
Synthesis of unnatural flavonoids and stilbenes by exploiting the plant biosynthetic pathway in Escherichia coli. |
XX-JUN-2007 |
29-JUL-2011 |
9435893 |
Regulation of retinoidal actions by diazepinylbenzoic acids. Retinoid synergists which activate the RXR-RAR heterodimers. |
13-FEB-1998 |
10-NOV-2009 |
9554881 |
Clarification of the binding mode of teleocidin and benzolactams to the Cys2 domain of protein kinase Cdelta by synthesis of hydrophobically modified, teleocidin-mimicking benzolactams and computational docking simulation. |
21-MAY-1998 |
10-NOV-2009 |
10229620 |
Potent estrogenic agonists bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore. |
03-JUN-1999 |
10-NOV-2009 |
10498208 |
Protein kinase C modulators bearing dicarba-CLOSO-dodecaborane as a hydrophobic pharmacophore. |
28-OCT-1999 |
10-NOV-2009 |
10021922 |
Synthesis, computer modeling and biological evaluation of novel protein kinase C agonists based on a 7-membered lactam moiety. |
11-MAY-1999 |
10-NOV-2009 |
10937721 |
Inhibition of dopamine receptors by endogenous amines: binding to striatal receptors and pharmacological effects on locomotor activity. |
06-DEC-2000 |
10-NOV-2009 |
10636245 |
Role of the hydrophobic moiety of tumor promoters. Synthesis and activity of 2-alkylated benzolactams. |
28-FEB-2000 |
10-NOV-2009 |
15050642 |
Parallel synthesis of DAPT derivatives and their gamma-secretase-inhibitory activity. |
30-MAR-2004 |
10-NOV-2009 |
16682195 |
Novel gamma-secretase inhibitors discovered by library screening of in-house synthetic natural product intermediates. |
05-JUN-2006 |
10-NOV-2009 |
15109656 |
Synthesis of 1alpha,25-dihydroxyvitamin D3-26,23-lactams (DLAMs), a novel series of 1 alpha,25-dihydroxyvitamin D3 antagonist. |
27-APR-2004 |
10-NOV-2009 |
16766183 |
Synthesis of biotinylated photoaffinity probes based on arylsulfonamide gamma-secretase inhibitors. |
04-AUG-2006 |
10-NOV-2009 |
16275077 |
Design and synthesis of substituted phenylpropanoic acid derivatives as human peroxisome proliferator-activated receptor alpha/delta dual agonists. |
26-DEC-2005 |
10-NOV-2009 |
17532641 |
Design, synthesis, and evaluation of potent, structurally novel peroxisome proliferator-activated receptor (PPAR) delta-selective agonists. |
12-JUN-2007 |
10-NOV-2009 |
17498949 |
Liver X receptor antagonists with a phthalimide skeleton derived from thalidomide-related glucosidase inhibitors. |
22-JUN-2007 |
10-NOV-2009 |
18343126 |
Co-existence of alpha-glucosidase-inhibitory and liver X receptor-regulatory activities and their separation by structural development. |
15-APR-2008 |
26-JUL-2008 |
17292610 |
Design, synthesis, and evaluation of non-steroidal farnesoid X receptor (FXR) antagonist. |
01-APR-2007 |
29-APR-2008 |